Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
基本信息
- 批准号:10681386
- 负责人:
- 金额:$ 331.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAddressAgricultureAppalachian RegionAwardCOVID-19 pandemicCardiovascular systemClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesComplementComputer softwareDedicationsDevelopmentDiabetes MellitusDisciplineDistressEconomicsEngineeringEnvironmentEpidemicFosteringFundingFutureGenerationsGrantGrowthHealthHealth SciencesHealth StatusHealthcareHomeInstitutionIntegrated Health Care SystemsInterventionInvestmentsKentuckyLeadLongevityMalignant NeoplasmsMedicalMedical centerMissionModelingNational Center for Advancing Translational SciencesNeurosciencesObesityParticipantPatientsPersonsPhasePoliciesPopulationPositioning AttributeQuality of lifeReportingResearchResourcesRuralRural CommunityRural HealthScienceSportsSubstance Use DisorderSubstance abuse problemTranslational ResearchTranslationsUnderserved PopulationUnited StatesUniversitiesWest VirginiaWorkaustinclinical centerclinical research sitecollaborative environmentcollegecommunity based participatory researchcommunity engagementdiversity and inclusionhealth disparityhealth equityhealth inequalitiesimprovedinnovationinter-institutionalnew technologyopioid abusepatient engagementprogramsrecruitresponserural area
项目摘要
Contact PD/PI: Kern, Philip A.
PROJECT SUMMARY – OVERALL
The University of Kentucky (UK) Center for Clinical and Translational Science (CCTS) has created an
integrated home for clinical and translational research which promotes scientific progress and discoveries at
every phase of the translational continuum. The CCTS has partnered with communities in Central Appalachia
to address multiple generations of recalcitrant health inequities related in part to the economic distress of rural
communities. The CCTS has fundamentally transformed UK and Central Appalachia through the development
of strong academic-community research networks and collaborations within the CTSA consortium.
Appalachian health disparities are further magnified by the opioid and substance abuse epidemic, which has
greatly impacted eastern Kentucky and West Virginia. The strong UK research portfolio puts the UK CCTS in
an optimal position to lead local, regional and national research efforts focused on rural health inequities.
The aligned missions of UK, UK HealthCare and the CCTS focus on achieving health equity by engaging in
highly innovative, collaborative and dynamic translational research to address rural health needs. The CCTS
will continue to educate the translational workforce of the future, engage rural communities in translational and
bi-directional team science and work with the national network to advance transdisciplinary research and
clinical trials through the following Specific Aims: 1) develop, innovate and transform our research environment
to promote impactful science and discovery within our integrated health care system to meet the unique health
needs of Central Appalachian residents; 2) lead institutional innovation in the delivery of impactful clinical and
translational research that covers the lifespan, fully engages the community and embraces team science; 3)
catalyze an efficient, university-wide clinical trials organization which adds value to the CTSA consortium by
engaging participants from rural Central Appalachia; and 4) foster and enhance a workforce characterized by
diversity and inclusivity across all translational science disciplines and populations. The UK CTSA hub is
uniquely positioned in the National CTSA Consortium to foster novel technologies, team science, clinical trial
start-up and cutting-edge translational research across the lifespan with a focus on rural communities. We
have a particular focus on the Central Appalachian community, a rural area with many of the highest levels of
health disparities in the nation. This focus will ultimately elevate the health and quality of life of rural
communities throughout the United States.
Project Summary/Abstract Page 276
Contact PD/PI: Kern, Philip A.
联系人 PD/PI:Kern, Philip A.
项目概要——总体
肯塔基大学(英国)临床和转化科学中心 (CCTS) 创建了一个
临床和转化研究的综合家园,促进科学进步和发现
CCTS 与中阿巴拉契亚地区的社区进行了合作。
解决多代人顽固的健康不平等问题,部分原因是农村经济困难
CCTS 通过发展从根本上改变了英国和阿巴拉契亚中部地区。
CTSA 联盟内强大的学术界研究网络和合作。
阿巴拉契亚地区的健康差距因阿片类药物和药物滥用的流行而进一步扩大,
英国强大的研究组合对肯塔基州东部和弗吉尼亚州产生了重大影响,使英国 CCTS 跻身其中。
领导以农村卫生不平等为重点的地方、区域和国家研究工作的最佳职位。
英国、英国医疗保健和 CCTS 的一致使命侧重于通过参与实现健康公平
CCTS 开展高度创新、协作和动态的转化研究,以满足农村卫生需求。
将继续教育未来的转化劳动力,让农村社区参与转化和
双向团队科学并与国家网络合作推进跨学科研究和
通过以下具体目标进行临床试验:1)开发、创新和改造我们的研究环境
在我们的综合医疗保健系统中促进有影响力的科学和发现,以满足独特的健康需求
中部阿巴拉契亚居民的需求;2) 在提供有影响力的临床和治疗方面引领机构创新;
涵盖生命周期、充分参与社区并拥抱团队科学的转化研究;3)
促进建立一个高效的、大学范围内的临床试验组织,通过以下方式为 CTSA 联盟增加价值
吸引来自阿巴拉契亚中部农村地区的参与者;以及 4) 培养和增强一支具有以下特征的劳动力队伍:
英国 CTSA 中心具有跨所有转化科学学科和人群的多样性和包容性。
在国家 CTSA 联盟中处于独特地位,致力于促进新技术、团队科学和临床试验
整个生命周期的初创和尖端转化研究,重点关注农村社区。
特别关注阿巴拉契亚中部社区,该农村地区拥有许多最高水平的
这种关注最终将提高农村地区的健康和生活质量。
美国各地的社区。
项目总结/摘要第 276 页
联系人 PD/PI:Kern, Philip A.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip A Kern其他文献
Philip A Kern的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip A Kern', 18)}}的其他基金
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10363388 - 财政年份:2021
- 资助金额:
$ 331.99万 - 项目类别:
Mirabegron and tadalafil effectiveness for treatment of prediabetes
米拉贝隆和他达拉非治疗糖尿病前期的有效性
- 批准号:
10532229 - 财政年份:2021
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10531210 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
人类米色脂肪组织的激活机制;
- 批准号:
10630687 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
Mechanisms for activation of beige adipose tissue in humans
人体米色脂肪组织的激活机制
- 批准号:
10308496 - 财政年份:2020
- 资助金额:
$ 331.99万 - 项目类别:
The activation of brown and beige fat and role in insulin sensitivity
棕色和米色脂肪的激活及其在胰岛素敏感性中的作用
- 批准号:
9241565 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10459638 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10185144 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
9314011 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
Kentucky Center for Clinical and Translational Science
肯塔基州临床和转化科学中心
- 批准号:
10733214 - 财政年份:2016
- 资助金额:
$ 331.99万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimizing the implementation of personalized risk-prediction models for venous thromboembolism among hospitalized adults
优化住院成人静脉血栓栓塞个性化风险预测模型的实施
- 批准号:
10658198 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
Center for Virtual Care Value and Equity (ViVE)
虚拟护理价值和公平中心 (ViVE)
- 批准号:
10621602 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
- 批准号:
10747551 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别:
Learning Precision Medicine for Rare Diseases Empowered by Knowledge-driven Data Mining
通过知识驱动的数据挖掘学习罕见疾病的精准医学
- 批准号:
10732934 - 财政年份:2023
- 资助金额:
$ 331.99万 - 项目类别: